World Health Organization 10 November, 2018 WHO Essential Medicines and Health Products Department Update WHO EMP July – Dec 2014 IPC Meeting World Bank, Washington DC, December 16- 17, 2014 Dr Kees de Joncheere

1- Access to Essential Medicines and other Health Technologies Area World Health Organization 1- Access to Essential Medicines and other Health Technologies Area 10 November, 2018 a) Involvement of WHO in Ebola Response for the last 6 months: R&D activities, preparedness and response in the field. b) Ebola and the challenges of the HS reconstruction including Pharmaceutical Systems: c) For the Assessment of procurement agencies: -ECSPP adopted the WHO Model quality assurance system. (MQAS) Model inspection report Revised product questionnaire (“interagency questionnaire”)

World Health Organization 1- Access to Essential Medicines and other Health Technologies Area 10 November, 2018 d) Preparation for the 10 years Good Governance in Medicines Programme; e) Medicines Transparency Alliance (MeTA) evaluation with participating countries; f) Preparation of the Expert Committee on Essential Medicines (April 2015): Review of oncology medicines; Hepatitis C Medicines; Update TB drugs and ARV

1- Access to Essential Medicines and other Health Technologies Area g) Medicines and UHC: Issue paper on high cost medicines and role of the HTA; h) Preparation of the Global Action Plan on the AMR: Meeting hosted by Norway on responsible use of antibiotics (Nov. 2014)

World Health Organization 2- Regulatory issues: Quality, Safety and Efficacy 10 November, 2018 a) Statement on value added of PQ; last updates on PQ for diagnostics and vaccines: b) MSM on SSFFC October 2014; New study on Public health and economic impact of SSFFC Prioritized workplan c) ICDRA: meeting in Brazil in August 2014. Pre meeting on Biosimilars. d) NRA Assesssment Tool: Consultation January 2015